Engineered Multivalency Enhances Affibody-Based HER3 Inhibition and Downregulation in Cancer Cells
about
Engineered Multivalency Enhances Affibody-Based HER3 Inhibition and Downregulation in Cancer Cells
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Engineered Multivalency Enhanc ...... Downregulation in Cancer Cells
@ast
Engineered Multivalency Enhanc ...... Downregulation in Cancer Cells
@en
type
label
Engineered Multivalency Enhanc ...... Downregulation in Cancer Cells
@ast
Engineered Multivalency Enhanc ...... Downregulation in Cancer Cells
@en
prefLabel
Engineered Multivalency Enhanc ...... Downregulation in Cancer Cells
@ast
Engineered Multivalency Enhanc ...... Downregulation in Cancer Cells
@en
P2093
P2860
P1476
Engineered Multivalency Enhanc ...... Downregulation in Cancer Cells
@en
P2093
Arif Hussain
Chloe M Aloimonos
James L Howard
Jinan M Oubaid
John S Schardt
Mariya S Liyasova
Maura O'Neill
Michelle L Bookstaver
Sonja Sokic
Sonya C Williams
P2860
P304
P356
10.1021/ACS.MOLPHARMACEUT.6B00919
P407
P577
2017-03-08T00:00:00Z